Brian M. Hahn - 12 Jan 2024 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Reporting relationship: SVP Finance, CFO
Issuer ticker: GLYC
Reported as of: 12 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jan 2024, 16:05:12 UTC
Prior SEC filing: 18 May 2023
Next SEC filing: 20 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Brian F. Leaf, attorney-in-fact

Key filing fact

Brian M. Hahn filed Form 4 for GLYCOMIMETICS INC (GLYC) on 17 Jan 2024.

Key facts

This page summarizes Brian M. Hahn's Form 4 filing for GLYCOMIMETICS INC (GLYC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Jan 2024, 16:05.

Change

Previous filing in this sequence was filed on 18 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GLYC transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +250,000
Change %
Price: $0.000000
Shares after: 250,000
Date: 12 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250,000
Exercise price: $3.11
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares underlying this option will vest on January 12, 2025 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date.